Works by Matasar, Matthew

Results: 49
    1

    Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01318-5
    By:
    • St-Pierre, Frederique;
    • Bhatta, Subodh;
    • Doukas, Peter G.;
    • Jenkin, Madeline;
    • Annunzio, Kaitlin;
    • Rojek, Alexandra E.;
    • Gibson, Alyssa;
    • Tiger, Yun Kyoung;
    • McCall, Brittany;
    • Alhamad, Khaled;
    • Hansen, Alec;
    • Alderuccio, Juan P.;
    • Adewale, Olutobi;
    • Patel, Keem;
    • Trabolsi, Asaad;
    • Lossos, Izidore S.;
    • Fitzgerald, Lindsey;
    • Ollila, Thomas A.;
    • Matasar, Matthew J.;
    • Kline, Justin
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era.

    Published in:
    British Journal of Haematology, 2023, v. 200, n. 4, p. 524, doi. 10.1111/bjh.18590
    By:
    • Qualls, David;
    • Imber, Brandon S.;
    • Okwali, Michelle;
    • Hamlin, Paul A.;
    • Kumar, Anita;
    • Lahoud, Oscar B.;
    • Matasar, Matthew J.;
    • Noy, Ariela;
    • Owens, Colette;
    • Zelenetz, Andrew D.;
    • North, Victoria S.;
    • Schöder, Heiko;
    • Dogan, Ahmet;
    • Salles, Gilles;
    • Yahalom, Joachim;
    • Falchi, Lorenzo
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S406, doi. 10.1016/S2152-2650(21)01916-9
    By:
    • Assouline, Sarit;
    • Won Seog Kim;
    • Sehn, Laurie H.;
    • Schuster, Stephen J.;
    • Chan Yoon Cheah;
    • Nastoupil, Loretta J.;
    • Shadman, Mazyar;
    • Sung-Soo Yoon;
    • Matasar, Matthew J.;
    • Diefenbach, Catherine;
    • Gregory, Gareth P.;
    • Bartlett, Nancy L.;
    • Wei, Michael C.;
    • Doral, Michelle Y.;
    • Shen Yin;
    • Negricea, Raluca;
    • Chi-Chung Li;
    • Penuel, Elicia;
    • Huang Huang;
    • Budde, L. Elizabeth
    Publication type:
    Article
    14

    Poster: IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01540-8
    By:
    • Assouline, Sarit;
    • Kim, Won Seog;
    • Sehn, Laurie H.;
    • Schuster, Stephen J.;
    • Cheah, Chan Yoon;
    • Nastoupil, Loretta J.;
    • Shadman, Mazyar;
    • Yoon, Sung-Soo;
    • Matasar, Matthew J.;
    • Diefenbach, Catherine;
    • Gregory, Gareth P.;
    • Bartlett, Nancy L.;
    • Wei, Michael C.;
    • Doral, Michelle Y.;
    • Yin, Shen;
    • Negricea, Raluca;
    • Li, Chi-Chung;
    • Penuel, Elicia;
    • Huang, Huang;
    • Budde, L. Elizabeth
    Publication type:
    Article
    15

    Managing Cytokine Release Syndrome and Neurotoxicity with Step-Up Dosing of Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S247, doi. 10.1016/j.clml.2019.07.151
    By:
    • Bartlett, Nancy L.;
    • Sehn, Laurie H.;
    • Assouline, Sarit;
    • Bosch, Francesc;
    • Diefenbach, Catherine M.;
    • Flinn, Ian;
    • Hong, Jung Yong;
    • Kim, Wonseog S.;
    • Matasar, Matthew;
    • Nastoupil, Loretta;
    • Schuster, Stephen J.;
    • Shadman, Mazyar;
    • Yoon, Sung-Soo;
    • Bender, Brendan;
    • Chu, Wayne;
    • Hernandez, Genevive;
    • Kwan, Antonia;
    • McCall, Bruce;
    • Sison, Iris;
    • Wang, Cunlin
    Publication type:
    Article
    16
    17

    Prospective Study of 3'-Deoxy-3'-<sup>18</sup>F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 5, p. 728, doi. 10.2967/jnumed.115.166769
    By:
    • Schöder, Heiko;
    • Zelenetz, Andrew D.;
    • Hamlin, Paul;
    • Gavane, Somali;
    • Horwitz, Steven;
    • Matasar, Matthew;
    • Moskowitz, Alison;
    • Noy, Ariela;
    • Palomba, Lia;
    • Portlock, Carol;
    • Straus, David;
    • Grewal, Ravinder;
    • Migliacci, Jocelyn C.;
    • Larson, Steven M.;
    • Moskowitz, Craig H.
    Publication type:
    Article
    18

    Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting.

    Published in:
    Cancers, 2023, v. 15, n. 6, p. 1760, doi. 10.3390/cancers15061760
    By:
    • Zheng, Serena;
    • Gupta, Kanika;
    • Goyal, Piyush;
    • Nakajima, Reiko;
    • Michaud, Laure;
    • Batlevi, Connie Lee;
    • Hamlin, Paul A.;
    • Horwitz, Steven;
    • Kumar, Anita;
    • Matasar, Matthew J.;
    • Moskowitz, Alison J.;
    • Moskowitz, Craig H.;
    • Noy, Ariela;
    • Palomba, M. Lia;
    • Straus, David J.;
    • Von Keudell, Gottfried;
    • Falchi, Lorenzo;
    • Yahalom, Joachim;
    • Zelenetz, Andrew D.;
    • Younes, Anas
    Publication type:
    Article
    19

    Fear of cancer recurrence in lymphoma survivors: A descriptive study.

    Published in:
    Journal of Psychosocial Oncology, 2020, v. 38, n. 3, p. 251, doi. 10.1080/07347332.2019.1677840
    By:
    • Latella, Lauren E.;
    • Rogers, Madeline;
    • Leventhal, Howard;
    • Parker, Patricia A.;
    • Horwitz, Steven;
    • Matasar, Matthew J.;
    • Bylund, Carma L.;
    • Kissane, David W.;
    • Franco, Kara;
    • Banerjee, Smita C.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26

    Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 6, p. N.PAG, doi. 10.1038/s41408-019-0209-5
    By:
    • Kumar, Anita;
    • Sha, Fushen;
    • Toure, Ahmed;
    • Dogan, Ahmet;
    • Ni, Andy;
    • Batlevi, Connie L.;
    • Palomba, Maria Lia M.;
    • Portlock, Carol;
    • Straus, David J.;
    • Noy, Ariela;
    • Horwitz, Steven M.;
    • Moskowitz, Alison;
    • Hamlin, Paul;
    • Moskowitz, Craig H.;
    • Matasar, Matthew J.;
    • Zelenetz, Andrew D.;
    • Younes, Anas
    Publication type:
    Article
    27
    28
    29

    Phase I/ II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation.

    Published in:
    British Journal of Haematology, 2015, v. 168, n. 5, p. 663, doi. 10.1111/bjh.13195
    By:
    • Straus, David J.;
    • Hamlin, Paul A.;
    • Matasar, Matthew J.;
    • Lia Palomba, Maria;
    • Drullinsky, Pamela R.;
    • Zelenetz, Andrew D.;
    • Gerecitano, John F.;
    • Noy, Ariela;
    • Hamilton, Audrey M.;
    • Elstrom, Rebecca;
    • Wegner, Brett;
    • Wortman, Katy;
    • Cella, David
    Publication type:
    Article
    30
    31
    32
    33

    Polatuzumab Vedotin plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Results from the Phase III POLARIX Study

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 56
    By:
    • Jurczak, Wojciech;
    • Tilly, Hervé;
    • Morschhauser, Franck;
    • Sehn, Laurie H.;
    • Friedberg, Jonathan W.;
    • Trněný, Marek;
    • Sharman, Jeff P.;
    • Herbaux, Charles;
    • Burke, John M.;
    • Matasar, Matthew;
    • Rai, Shinya;
    • Koji Izutsu;
    • Mehta-Shah, Neha;
    • Oberic, Lucie;
    • Chauchet, Adrien;
    • Yuqin Song;
    • Greil, Richard;
    • Mykhalska, Larysa;
    • Bergua Burgués, Juan Miguel;
    • Cheung, Matthew C.
    Publication type:
    Article
    34

    Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00620-w
    By:
    • Sha, Fushen;
    • Okwali, Michelle;
    • Alperovich, Anna;
    • Caron, Philip C.;
    • Falchi, Lorenzo;
    • Hamilton, Audrey;
    • Hamlin, Paul A.;
    • Horwitz, Steven M.;
    • Joffe, Erel;
    • Khan, Niloufer;
    • Kumar, Anita;
    • Matasar, Matthew J.;
    • Moskowitz, Alison J.;
    • Noy, Ariela;
    • Owens, Colette;
    • Palomba, Lia M.;
    • Rodriguez-Rivera, Ildefonso;
    • Straus, David;
    • von Keudell, Gottfried;
    • Zelenetz, Andrew D.
    Publication type:
    Article
    35

    Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00506-3
    By:
    • Bobillo, Sabela;
    • Joffe, Erel;
    • Sermer, David;
    • Mondello, Patrizia;
    • Ghione, Paola;
    • Caron, Philip C.;
    • Hamilton, Audrey;
    • Hamlin, Paul A.;
    • Horwitz, Steven M.;
    • Kumar, Anita;
    • Matasar, Matthew J.;
    • Batlevi, Connie L.;
    • Moskowitz, Alison;
    • Noy, Ariela;
    • Owens, Collette N.;
    • Palomba, M. Lia;
    • Straus, David;
    • von Keudell, Gottfried;
    • Dogan, Ahmet;
    • Zelenetz, Andrew D.
    Publication type:
    Article
    36

    Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 7, p. N.PAG, doi. 10.1038/s41408-020-00340-z
    By:
    • Batlevi, Connie L.;
    • Sha, Fushen;
    • Alperovich, Anna;
    • Ni, Ai;
    • Smith, Katy;
    • Ying, Zhitao;
    • Soumerai, Jacob D.;
    • Caron, Philip C.;
    • Falchi, Lorenzo;
    • Hamilton, Audrey;
    • Hamlin, Paul A.;
    • Horwitz, Steven M.;
    • Joffe, Erel;
    • Kumar, Anita;
    • Matasar, Matthew J.;
    • Moskowitz, Alison J.;
    • Moskowitz, Craig H.;
    • Noy, Ariela;
    • Owens, Colette;
    • Palomba, Lia M.
    Publication type:
    Article
    37

    Mosunetuzumab Monotherapy Demonstrates Durable Efficacy and Manageable Safety in Patients With Relapsed/Refractory Follicular Lymphoma and =2 Prior Therapies: Updated Results From a Pivotal Phase 2 Study.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 359
    By:
    • Bartlett, Nancy L.;
    • Sehn, Laurie H.;
    • Matasar, Matthew;
    • Schuster, Stephen J.;
    • Assouline, Sarit;
    • Giri, Pratyush;
    • Kuruvilla, John;
    • Canales, Miguel;
    • Dietrich, Sascha;
    • Fay, Keith;
    • Ku, Matthew;
    • Nastoupil, Loretta;
    • Wei, Michael C.
    Publication type:
    Article
    38
    39

    Romidepsin and lenalidomide‐based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. 1211, doi. 10.1002/ajh.26288
    By:
    • Mehta‐Shah, Neha;
    • Lunning, Matthew A.;
    • Moskowitz, Alison J.;
    • Boruchov, Adam M.;
    • Ruan, Jia;
    • Lynch, Peggy;
    • Hamlin, Paul A.;
    • Leonard, John;
    • Matasar, Matthew J.;
    • Myskowski, Patricia L.;
    • Marzouk, Evan;
    • Nair, Sumithra;
    • Sholklapper, Tamir;
    • Minnal, Veena;
    • Palomba, Maria L.;
    • Vredenburgh, James;
    • Kumar, Anita;
    • Noy, Ariela;
    • Straus, David J.;
    • Zelenetz, Andrew D.
    Publication type:
    Article
    40

    Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 10, p. 1380, doi. 10.1093/neuonc/nox086
    By:
    • Thomas, Alissa A.;
    • Abrey, Lauren E.;
    • Terziev, Robert;
    • Raizer, Jeffrey;
    • Martinez, Nina L.;
    • Forsyth, Peter;
    • Paleologos, Nina;
    • Matasar, Matthew;
    • Sauter, Craig S.;
    • Moskowitz, Craig;
    • Nimer, Stephen D.;
    • DeAngelis, Lisa M.;
    • Kaley, Thomas;
    • Grimm, Sean;
    • Louis, David N.;
    • Cairncross, J. Gregory;
    • Panageas, Katherine S.;
    • Briggs, Samuel;
    • Faivre, Geraldine;
    • Mohile, Nimish A.
    Publication type:
    Article
    41
    42
    43
    44

    Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 4, p. 876, doi. 10.1080/10428194.2021.2002318
    By:
    • Pak, Terry K.;
    • Dixon, Brianne N.;
    • Buege, Michael J.;
    • Dao, Phuong H.;
    • Leary, Megan H.;
    • Jarrett, Joy C.;
    • Duggan, Tara A.;
    • Caron, Philip;
    • Falchi, Lorenzo;
    • Hamlin, Paul;
    • Hamilton, Audrey;
    • Matasar, Matthew J.;
    • Moskowitz, Alison;
    • Noy, Ariela;
    • Owens, Colette N.;
    • Von Keudell, Gottfried;
    • Younes, Anas;
    • Zelenetz, Andrew D.;
    • Kumar, Anita
    Publication type:
    Article
    45
    46
    47
    48
    49